{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:18:32Z","timestamp":1787905112325,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":777,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care and Resuscitation"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.51893\/2021.3.oa10","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:11:28Z","timestamp":1630559488000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The cost-effectiveness of early goal-directed therapy: an economic evaluation alongside the ARISE trial"],"prefix":"10.1016","volume":"23","author":[{"given":"Alisa M.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Peake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.O.","family":"Rinaldo Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Jamie Cooper","family":"AO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda D.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair D.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.51893\/2021.3.OA10_bb0005","doi-asserted-by":"crossref","unstructured":"Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority \u2014 a WHO resolution. N Engl J Med 2017; 377: 414-7.","DOI":"10.1056\/NEJMp1707170"},{"key":"10.51893\/2021.3.OA10_bb0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.51893\/2021.3.OA10_bb0015","series-title":"George Institute for Global Health and Australian Sepsis Network. Stopping sepsis: a national action plan","year":"2017"},{"key":"10.51893\/2021.3.OA10_bb0020","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med"},{"key":"10.51893\/2021.3.OA10_bb0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/CCM.0000000000003762","article-title":"Quality of life and 1-year survival in patients with early septic shock: long-term follow-up of the Australasian Resuscitation in Sepsis Evaluation trial","volume":"47","author":"Higgins","year":"2019","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40560-019-0412-2","article-title":"Health economic evaluations of sepsis interventions in critically ill adult patients: a systematic review","volume":"8","author":"Higgins","year":"2020","journal-title":"J Intensive Care"},{"issue":"692","key":"10.51893\/2021.3.OA10_bb0035","first-page":"e1","article-title":"The cost-effectiveness ratio of a managed protocol for severe sepsis","volume":"29","author":"Assuncao","year":"2014","journal-title":"J Crit Care"},{"key":"10.51893\/2021.3.OA10_bb0040","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/CCM.0b013e31821201be","article-title":"Cost-effectiveness of an emergency department-based early sepsis resuscitation protocol","volume":"39","author":"Jones","year":"2011","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0045","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.51893\/2021.3.OA10_bb0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00134-013-3131-5","article-title":"Implementation of a multifaceted sepsis education program in an emerging country setting: clinical outcomes and cost-effectiveness in a long-term follow-up study","volume":"40","author":"Noritomi","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.51893\/2021.3.OA10_bb0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-010-2102-3","article-title":"Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain","volume":"37","author":"Suarez","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.51893\/2021.3.OA10_bb0060","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/CCM.0b013e318168f649","article-title":"The costs and cost-effectiveness of an integrated sepsis treatment protocol","volume":"36","author":"Talmor","year":"2008","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0065","first-page":"162","article-title":"The Australasian Resuscitation in Sepsis Evaluation (ARISE) trial statistical analysis plan","volume":"15","author":"Delaney","year":"2013","journal-title":"Crit Care Resusc"},{"key":"10.51893\/2021.3.OA10_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"10.51893\/2021.3.OA10_bb0075","series-title":"A social tariff for EuroQol: results from a UK general population survey","author":"Dolan","year":"1995"},{"key":"10.51893\/2021.3.OA10_bb0080","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1089\/neu.2018.6229","article-title":"Cost-effectiveness of erythropoietin in traumatic brain injury: a multinational trial-based economic analysis","volume":"36","author":"Knott","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.51893\/2021.3.OA10_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19970","article-title":"Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock","volume":"19","author":"Mouncey","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.51893\/2021.3.OA10_bb0090","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S2213-2600(16)30120-5","article-title":"Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST","volume":"4","author":"Taylor","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.51893\/2021.3.OA10_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50 000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.51893\/2021.3.OA10_bb0100","series-title":"Economic evaluation in clinical trials","author":"Glick","year":"2007"},{"key":"10.51893\/2021.3.OA10_bb0105","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/01.CCM.0000281636.82971.92","article-title":"Implementation of early goal-directed therapy for severe sepsis and septic shock: a decision analysis","volume":"35","author":"Huang","year":"2007","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0110","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.51893\/2021.3.OA10_bb0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2017.17687","article-title":"Enhancing recovery from sepsis: a review","volume":"319","author":"Prescott","year":"2018","journal-title":"JAMA"},{"key":"10.51893\/2021.3.OA10_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.aucc.2017.08.004","article-title":"The evolution of Australian intensive care and its related costs: a narrative review","volume":"31","author":"Thompson","year":"2018","journal-title":"Aust Crit Care"},{"key":"10.51893\/2021.3.OA10_bb0125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0130","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/CCM.0b013e318232db65","article-title":"Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007","volume":"40","author":"Lagu","year":"2012","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0135","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/CCM.0000000000003342","article-title":"Epidemiology and costs of sepsis in the United States \u2014 an analysis based on timing of diagnosis and severity level","volume":"46","author":"Paoli","year":"2018","journal-title":"Crit Care Med"},{"key":"10.51893\/2021.3.OA10_bb0140","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.51893\/2021.3.OA10_bb0145","doi-asserted-by":"crossref","unstructured":"Peake SL, Delaney A, Bailey M, Bellomo R, Investigators ARISE. Potential impact of the 2016 consensus definitions of sepsis and septic shock on future sepsis research. Ann Emerg Med 2017; 70: 553-61.","DOI":"10.1016\/j.annemergmed.2017.04.007"}],"container-title":["Critical Care and Resuscitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144127722300501X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144127722300501X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T11:22:51Z","timestamp":1699269771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144127722300501X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S144127722300501X"],"URL":"https:\/\/doi.org\/10.51893\/2021.3.oa10","relation":{},"ISSN":["1441-2772"],"issn-type":[{"value":"1441-2772","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cost-effectiveness of early goal-directed therapy: an economic evaluation alongside the ARISE trial","name":"articletitle","label":"Article Title"},{"value":"Critical Care and Resuscitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.51893\/2021.3.OA10","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 College of Intensive Care Medicine of Australia and New Zealand.","name":"copyright","label":"Copyright"}]}}